NewsBenzingaJasper Therapeutics任命Jeet Mahal为临时首席财务官，自2026年10月9日起生效；Herb Cross辞去首席财务官职务，自2026年10月9日起生效 Jasper Therapeutics任命Jeet Mahal为临时首席财务官，自2026年10月9日起生效；Herb Cross辞去首席财务官职务，自2026年10月9日起生效 Benzinga 2026.09.28 20:48 (GMT+0) Open on Benzinga Other news Barclays Maintains Equal-Weight on Exelon, Lowers Price Target to $44 The FTC Allows Publicis’ LiveRamp Acquisition To Move Forward With Safeguards To Protect Customer Data And Fair Competition. Citizens Financial Analysts Slash Their Forecasts Following Q3 Results Barclays Maintains Overweight on Evergy, Lowers Price Target to $86 Mastercard Brings Its Fraud-Fighting Tools to Stablecoin Payments Barclays Maintains Overweight on Entergy, Lowers Price Target to $115
The FTC Allows Publicis’ LiveRamp Acquisition To Move Forward With Safeguards To Protect Customer Data And Fair Competition.
